Panelists discuss how future RWE should expand to include survival, quality of life, and safety data to improve third-line mCRC care. Panelists identify gaps in current evidence and the need for more ...

Panelists discuss how RWE helps guide sequencing choices when head-to-head trial data are lacking in third-line metastatic colorectal cancer. Panelists explain that in the absence of head-to-head ...

Builds on existing partnership by further leveraging the combined power of real-world data, real-world evidence and privacy-preserving record linkage technology to help solve key clinical trial ...

The traditional process for evaluating new therapeutics may not generate the evidence that patients, clinicians, and payers need to make real-world decisions. The volume and complexity of information ...